Kelly Mizer
Business/Corporate Development, Commercialization, Portfolio Strategy | Gene Therapy, Rare Diseases, Cardiovascular, Oncology, Ophthalmology
- Role
- Executive Director, New Product Commercial Strategy at Ionis Pharmaceuticals, Inc.
- Location
- Cambridge, MA, US
- LinkedIn followers
- 500 followers
About Kelly Mizer
Dedicated life science leader with a profound passion for enhancing patient well-being through transformative treatments. Boasting a distinguished track record of over two decades, excelled in driving commercial portfolio success, shaping corporate strategy, fostering business development, partnering with research and clinical development, and expertly managing alliances. An unwavering commitment to advancing healthcare aligns with a dedicated focus on providing patients with innovative solutions that make a meaningful impact on their lives.
Experience
Executive Director, New Product Commercial Strategy
Jun 2024 — Present · Boston, MA, US
Education
Boston University
MS, Applied Anatomy & Physiology
1999 — 2002
Boston University
BS, Human Physiology
1995 — 1999
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.